Hauptkonkurrenten
Dividendenrendite (N) Dividendenrendite (N+1) KGV (N) Price to Book (N) EV / Sales (N) Marktkap. / EBITDA (N) Marktkap. / EBIT (N) Kap.($)
- - - - - - - 319’235
0.82%0.91%35.57x4.99x6.72x23.2x28.06x 48.36 Mrd.
1.3%1.39%18.36x1.8x2.08x9.81x12.71x 35.8 Mrd.
0.88%1%27.36x3.02x3.33x17.22x21.75x 11.83 Mrd.
0.6%0.61%26.28x3.61x3.88x15.8x21.64x 11.48 Mrd.
3.48%3.84%19.15x3.27x3.34x12x14.26x 9.01 Mrd.
3.22%3.18%16.13x1.29x2.08x6.99x9.56x 6.99 Mrd.
5.34%5.71%8.12x1.4x1.9x4.97x6.02x 6.7 Mrd.
0.24%0.24%33.27x5.89x3.78x16.1x17.78x 6.42 Mrd.
0.98%1.18%40.18x9.24x7.7x28.54x31.86x 4.37 Mrd.
3.22%3.71%16.57x2.69x2.67x12.45x12.02x 4.17 Mrd.
1.31%1.77%15.01x0.72x2.05x8.85x11.24x 3.86 Mrd.
2.94%3.02%13.48x2.72x3.13x11.67x12.9x 2.68 Mrd.
3.15%3.5%19.14x5.13x5.97x16.96x18.35x 2.66 Mrd.
Durchschnitt 2.11% 2.31% 22.20x 3.52x 3.74x 14.20x 16.78x 11.02 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 1.51% 1.65% 25.57x 3.52x 4.16x 15.81x 19.33x
Generische Pharmazeutika